title: High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis.
authors.affiliation: University of Leeds, Leeds, UK.
authors.forename: Sarah
authors.initials: S
authors.lastname: Bingham
authors.forename: Douglas
authors.initials: D
authors.lastname: Veale
authors.forename: Ursula
authors.initials: U
authors.lastname: Fearon
authors.forename: John D
authors.initials: JD
authors.lastname: Isaacs
authors.forename: Gareth
authors.initials: G
authors.lastname: Morgan
authors.forename: Paul
authors.initials: P
authors.lastname: Emery
authors.forename: Dennis
authors.initials: D
authors.lastname: McGonagle
authors.forename: Richard
authors.initials: R
authors.lastname: Reece
authors.forename: Roy
authors.initials: R
authors.lastname: Clague
authors.forename: John A
authors.initials: JA
authors.lastname: Snowden
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000473:pathology / Q000628:therapy*; D001182:Arthroscopy; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016879:Salvage Therapy; D012720:Severity of Illness Index; D013585:Synovitis / Q000209:etiology / Q000473:pathology; D014182:Transplantation, Autologous
chemical_list: D018501:Antirheumatic Agents; D003520:Cyclophosphamide